Clinician's commentary: Atypical peritoneal cytology in ovarian and endometrial cancers

Abstract

Peritoneal cytology results play an important role in staging, prognostication, and treatment recommendations in early‐stage ovarian cancer. In endometrial cancer, while no longer part of staging criteria, peritoneal cytology results can influence patient‐provider shared‐decision making regarding adjuvant therapy choices after definitive surgery. We explore two cases demonstrating the impact uncertain cytology can have on patients and providers in these two gynecologic cancers.